Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms

Polypharmacy, potentially inappropriate medications (PIMs), and drug-to-drug interactions (DDIs) are highly prevalent in the elderly and may have adverse effects on health-related outcomes. Their occurrence and clinical and prognostic associations in patients with chronic myeloproliferative neoplasm...

Full description

Bibliographic Details
Main Authors: Ivan Krečak, Ljerka Pivac, Marko Lucijanić, Marko Skelin
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Biomedicines
Subjects:
myeloproliferative neoplasms
polypharmacy
drug interactions
survival
thrombosis
Online Access:https://www.mdpi.com/2227-9059/11/5/1301

Internet

https://www.mdpi.com/2227-9059/11/5/1301

Similar Items